SEC FORM 4
$398,855.04
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Sale of 1,758 shares at $226.88 per share.
Reporting Person SUPRAN BRYAN · Officer Title EVP, CLO and Secretary · Transaction Code S
Traded Oct 2, 2026 · Disclosed Oct 6, 2026
Source: SEC Form 4 · 0001178670-26-000068 · filed 2026-10-06 · View filing →